Androgen receptor-mediated upregulation of quaking affects androgen receptor-related prostate cancer development and anti-androgen receptor therapy

被引:7
作者
Zhang, Keke [1 ]
Yan, Fei [1 ]
Lei, Xiaoying [2 ]
Wei, Di [1 ]
Lu, Huanyu [2 ]
Zhu, Zheng [1 ]
Xiang, An [2 ]
Ye, Zichen [2 ]
Wang, Li [2 ]
Zheng, Wanxiang [1 ]
Li, Xi'an [1 ]
Yuan, Jiarui [3 ]
Lu, Zifan [2 ]
Yuan, Jianlin [1 ]
机构
[1] Fourth Mil Med Univ, Xijing Hosp, Dept Urol, 15 Changle Xi Rd, Xian 710032, Shaanxi, Peoples R China
[2] Fourth Mil Med Univ, Sch Pharm, Dept Pharmacogen, State Key Lab Canc Biol, 169 Changle Xi Rd, Xian 710032, Shaanxi, Peoples R China
[3] Univ Washington, Dept Biochem, Seattle, WA 98195 USA
基金
美国国家科学基金会;
关键词
androgen receptor; prostate-specific antigen; quaking; prostate cancer; drug sensitive; EXPRESSION; RNA; QKI; RESISTANCE; CARCINOMA; VARIANT; HSP90;
D O I
10.3892/mmr.2018.8882
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
The androgen receptor (AR) has a crucial role in prostate cancer. RNA-binding protein-mediated post-transcriptional regulation is important in the initiation and development of cancer. The present study attempted to elucidate the mutual association of AR and RNA-binding protein quaking (QKI) in the development of prostate cancer. Dual-luciferase reporter demonstrated that AR can positively regulate the expression of QKI in prostate cancer cell lines due to its effective transcription regulating function. In addition, QKI may increase expression of AR by heat shock protein 90, which is a coactivator of AR, and silencing QKI can increase the sensitive of Casodex, which is an antagonist of AR in castration-resistant prostate cancer. This may be a new strategy for advanced prostate cancer.
引用
收藏
页码:8203 / 8211
页数:9
相关论文
共 23 条
[11]   Constitutively-active androgen receptor variants function independently of the HSP90 chaperone but do not confer resistance to HSP90 inhibitors [J].
Gillis, Joanna L. ;
Selth, Luke A. ;
Centenera, Margaret M. ;
Townley, Scott L. ;
Sun, Shihua ;
Plymate, Stephen R. ;
Tilley, Wayne D. ;
Butler, Lisa M. .
ONCOTARGET, 2013, 4 (05) :691-704
[12]   Role of Heat Shock Proteins in Diseases and Their Therapeutic Potential [J].
Kaul, Gautam ;
Thippeswamy, Hitesh .
INDIAN JOURNAL OF MICROBIOLOGY, 2011, 51 (02) :124-131
[13]   Small-interfering RNA-induced androgen receptor silencing leads to apoptotic cell death in prostate cancer [J].
Liao, XB ;
Tang, SQ ;
Thrasher, JB ;
Griebling, TL ;
Li, BY .
MOLECULAR CANCER THERAPEUTICS, 2005, 4 (04) :505-515
[14]   AR Variant ARv567es Induces Carcinogenesis in a Novel Transgenic Mouse Model of Prostate Cancer [J].
Liu, Gang ;
Sprenger, Cynthia ;
Sun, Shihua ;
Epilepsia, Kathryn Soriano ;
Haugk, Kathleen ;
Zhang, Xiaotun ;
Coleman, Ilsa ;
Nelson, Peter S. ;
Plymate, Stephen .
NEOPLASIA, 2013, 15 (09) :1009-1017
[15]   Analysis of relative gene expression data using real-time quantitative PCR and the 2-ΔΔCT method [J].
Livak, KJ ;
Schmittgen, TD .
METHODS, 2001, 25 (04) :402-408
[16]   Genomic profiling identifies discrete deletions associated with translocations in glioblastoma multiforme [J].
Mulholland, Paul J. ;
Fiegler, Heike ;
Mazzanti, Chiara ;
Gorman, Patricia ;
Sasieni, Peter ;
Adams, Joanna ;
Jones, Tania A. ;
Babbage, Jane W. ;
Vatcheva, Radost ;
Ichimura, Koichi ;
East, Philip ;
Poullikas, Chrysanthos ;
Collins, V. Peter ;
Carter, Nigel P. ;
Tomlinson, Ian P. M. ;
Sheer, Denise .
CELL CYCLE, 2006, 5 (07) :783-791
[17]   Splicing variant of androgen receptors (AR-V7): New paradigms [J].
Penel, Nicolas .
BULLETIN DU CANCER, 2016, 103 (09) :711-713
[18]  
Siegel RL, 2021, CA-CANCER J CLIN, V71, P7, DOI [10.3322/caac.21654, 10.3322/caac.20006, 10.3322/caac.21332, 10.3322/caac.21254, 10.3322/caac.21601, 10.3322/caac.20073, 10.3322/caac.21387, 10.3322/caac.21551]
[19]  
YANG G, 2010, GASTROENTEROLOGY, V138
[20]   Post- transcriptional repression of FOXO1 by QKI results in low levels of FOXO1 expression in breast cancer cells [J].
Yu, Fang ;
Jin, Liang ;
Yang, Guodong ;
Ji, Lin ;
Wang, Feng ;
Lu, Zifan .
ONCOLOGY REPORTS, 2014, 31 (03) :1459-1465